Severe complications of chickenpox in hospitalised children in the UK and Ireland

Archives of Disease in Childhood

Volumn 92, Issue 12, 2007, Pages 1062-1066

  Cameron, J Claire ^a   Allan, G ^a   Johnston, F ^a   Finn, A ^b   Heath, P T ^c   Booy, R ^d  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATAXIA; BACTEREMIA; BLOOD CLOTTING DISORDER; CHICKENPOX; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENCEPHALITIS; FULMINATING PURPURA; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; IRELAND; MORTALITY; NECROTIZING FASCIITIS; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; SEPTIC SHOCK; TOXIC SHOCK SYNDROME; UNITED KINGDOM;

ADOLESCENT; AGE DISTRIBUTION; BACTERIAL INFECTIONS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; LENGTH OF STAY; MALE; OPPORTUNISTIC INFECTIONS; SEASONS;

EID: 36849044647     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.123232     Document Type: Article

References (37)

1. Gershon AA, Takahashi M, Seward J. Varicella vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines, 4th ed. Philadelphia: WB Saunders, 2004:783-823.
2. Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health 2000;3(4):282-7.
3. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 2003;70(Suppl 1):S9-14.
4. Ross AM, Fleming DM. Chickenpox increasingly affects preschool children. Commun Dis Public Health 2000;3(3):213-15.
5. Salisbury D, Ramsay M, Noakes K, eds. Immunisation against infectious disease. 3rd ed. London: Stationary Office, 2006.
6. Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ 2001;323:1091-3.
7. British Paediatric Surveillance Unit. BPSU 20th Annual Report, 2005-6. London: Royal College of Paediatrics and Child Health, 2007.
8. Joseph CA, Noah ND. Epidemiology of chickenpox in England and Wales, 1967-85. BMJ 1988;296:673-6.
9. Ziebold C, von Kries R, Lang R, et al. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001;108(5):E79.
10. Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 2005;164(6):366-70.
11. Sáez-Llorens X, De Suman O, De Morós D, et al. [Complications and costs associated with chickenpox in immunocompetent children]. Rev Panam Salud Publica 2002;12(2):111-16.
12. Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis 1996;23(4):698-705.
13. Koturoglu G, Kurugol Z, Cetin N, et al. Complications of varicella in healthy children in Izmir, Turkey. Pediatr Int 2005;47(3):296-9.
14. Perez-Yarza EG, Arranz L, Alustiza J, et al. [Hospital admissions for varicella complications in children aged less than 15 years old]. An Pediatr (Barc) 2003;59(3):229-33.
15. Piqueras Arenas AI, Otero Reigada MC, Perez-Tamarit D, et al. [Hospitalizations for varicella in the Hospital Infantil La Fe, Valencia, Spain, 2001-2004]. An Pediatr (Barc) 2005;63(2):120-4.
16. Law B, MacDonald N, Halperin S, et al. The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J 2000;19(11):1053-9.
17. Giocchino R, Losurdo G, Castagnola E. Decline in mortality with varicella vaccination. N Engl J Med 2005;352(17):1819.
18. Mallet E, Maitre M, Delalande-Dutilleul L, et al. [Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France]. Arch Pediatr 2004;11(9):1145-51.
19. Guess HA, Broughton DD, Melton LJ, et al. Population-based studies of varicella complications. Pediatrics 1986;78(4 Pt 2):723-7.
20. Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in a defined central European population. Arch Dis Child 1998;79(6): 472-7.
21. Choo PW, Donahue JG, Manson JE, et al. The epidemiology of varicella and its complications. J Infect Dis 1995;172(3):706-12.
22. Peterson CL, Mascola L, Chao SM, et al. Children hospitalized for varicella: a prevaccine review. J Pediatr 1996;129(4):529-36.
23. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992;11(6):441-5.
24. Ruben F, Streiff E, Neal M, et al. Epidemiologic features of Reye syndrome seen in southwestern Pennsylvania 1970-80. Am J Public Health 1983;73(9):1063-5.
25. Meyer PA, Seward JF, Jumaan AO, et al. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182(2):383-90.
26. Tseng HW, Liu CC, Wang SM, et al. Complications of varicella in children: emphasis on skin and central nervous system disorders. J Microbiol Immunol Infect 2000;33(4):248-52.
27. Forrest JM, Mego S, Burgess MA. Congenital and neonatal varicella in Australia. J Pediatr Child Health 2000;36:108-13.
28. Gershon AA, Mervish N, LaRussa P, et al. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect Dis 1997;176(6):1496-500.
29. Leibovitz E, Cooper D, Giurgiutiu D, et al. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus. Pediatrics 1993;92(6):838-42.
30. CDC. Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007;56(RR04):1-40.
31. Quinlivan ML, Gershon AA, Al Bassam MM, et al. Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci USA 2007;104(1):208-12.
32. Peadon E, Burgner D, Nissen M, et al. Case for varicella surveillance in Australia. J Pediatr Child Health 2006;42:663-4.
33. Clements DA, Zaref JI, Bland CL, et al. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med 2001;155(4):455-61.
34. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003;70(Suppl 1):S31-7.
35. Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance Scheme (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005;5(1):68.
36. Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005;191(12):2002- 7.
37. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352(22):2271-84.